5 Korean Skincare Brands On Our Radar
The gap between what Korea has proven and what the rest of the world has noticed.
By A Drop of Seoul Editorial ·
The most useful thing about living here is knowing what hasn't crossed over yet.
There's always a lag between a brand proving itself in Korea and anyone abroad hearing about it — sometimes three years, sometimes never. And the brands that close that gap aren't necessarily the best ones. They're the ones with an English-language marketing budget.
So this is a list built the other way round: strong evidence at home, thin profile everywhere else. Some of these will be on your shelf in two years. Some never will, and that will be a shame.
ON OUR RADAR is a series. This is the first one.
Quick answer
Zeroid — the barrier brand in most Korean dermatology clinics, only recently on retail shelves. goodal — Clio's vitamin C line, a permanent fixture in the serum rankings. 107 — fermented vinegar skincare from a brewery lineage, launched in America before Korea. Fillimilli — the beauty-tools brand that quietly won its category. Aestura — already on our starter list, and the one whose next two years we're actually watching.
1. Zeroid (제로이드)
The case: this is the brand your Korean dermatologist hands you, and it has been since 2002 — when it launched specifically for the hospital and clinic channel rather than for shops.
The numbers behind that are genuinely striking. Its Intensive Cream is distributed in roughly 70% of domestic dermatology clinics and 80% of pediatric clinics. Not marketed to them. Stocked by them.
What it's built on: a proprietary lamellar-structure technology the company calls MLE, designed to mimic the multi-layered organization of healthy skin barrier, plus an ingredient line they call Defensamide. Whether that outperforms a well-made ceramide cream is a fair question. What isn't in question is that Korean clinics have been dispensing it for two decades.
Why it's on the radar now: it moved into retail. A brand built for the clinic channel showing up on Olive Young shelves — where it picked up an MD's Pick in cream in 2025 — is exactly the kind of crossover worth watching.
Who it's for: eczema-prone, atopic, or genuinely reactive skin. Not a glow product. Our barrier repair routine is the context.
2. goodal (구달)
The case: goodal is Clio's clean-naturalist line, and its green tangerine vitamin C dark-spot serum has been a fixture in Olive Young's essence and serum rankings for years — placing second again in 2025. Its heartleaf sun cream also placed in suncare that year.
What's interesting: vitamin C is the category where Korean skincare has the weakest international reputation, largely because the Western conversation is dominated by high-percentage L-ascorbic acid formulas that sting. goodal's approach — green tangerine as the vitamin C source, plus derivatives — sits in a gentler register and has quietly outsold most of the alternatives here for years.
Who it's for: post-acne marks, uneven tone, and anyone who's tried a strong vitamin C serum and found their skin objected.
Why it's under-known abroad: Clio exports its color brands far more aggressively than its skincare, so goodal has never had the international push its domestic numbers would justify.
3. 107 (원오세븐)
The case: the best origin story on this list, and it's not marketing.
The brand comes out of a traditional Korean fermented-vinegar brewery, and the founding observation was about the skin of the artisans who worked there. The name refers to 107 family remedies passed down through generations. The founder developed adult-onset atopic dermatitis and built the line around gentle fermentation.
The genuinely odd part: it launched in the United States in 2020 and only entered the Korean market in January 2021. A Korean heritage brand that was reverse-imported into Korea. We can't think of another one that did it in that order.
Who it's for: people drawn to fermentation and hanbang-adjacent skincare who want something with an actual lineage rather than a lineage-shaped campaign.
Our honest caveat: we like the story and the positioning more than we can vouch for any single product. Fermentation as a category is long on tradition and short on comparative data. Treat this as a brand we find genuinely interesting rather than a specific recommendation.
4. Fillimilli (필리밀리)
The case: it won the beauty tools category in Olive Young's 2025 awards with a heated eyelash curler.
Why that's on a skincare list: because tools are the most systematically ignored category in Korean beauty exports, and it makes no sense. Brushes, sponges, curlers, spatulas, the little silicone things — Korea makes them well and cheaply, and essentially nobody writes about them.
We keep buying the curler as a gift. It costs almost nothing. It reliably produces the reaction that a much more expensive serum does not.
Who it's for: anyone who has ever been disappointed by a beauty tool, which is everyone.
Why it'll probably never go global: tools don't have a story, and the export machine runs on stories.
5. Aestura (에스트라) — the one we're watching
Full disclosure: this is also on our starter list, so it isn't a discovery. It's here because of the question it's about to answer.
Aestura is Euromonitor's number one dermocosmetic skincare brand in Korea by 2025 retail sales, with a derma heritage tracing back to a pharmaceutical division founded in 1982. Its Atobarrier365 Cream has taken Olive Young's cream category two years running, and Amorepacific's own figure is that one sells roughly every five seconds. It entered Sephora in the US, then Canada, Australia, and China, and has been expanding into major European markets.
The question: Korean beauty went global on glow — the dewy, luminous, aspirational end. The derma tier is the opposite proposition. It's clinical, unglamorous, and sells on trust rather than transformation.
Whether that travels is genuinely unresolved. If it does, the next decade of K-beauty abroad looks very different from the last one, and this is the brand we'd watch to find out.
What's actually driving this
One structural fact explains why a list like this is possible at all: in Olive Young's 2025 awards, about 75% of the first-place categories went to small and mid-size companies rather than conglomerates.
The Korean beauty market has become genuinely bottom-up. A brand can now win a category on formulation and repeat purchase without a chaebol behind it — which means the interesting names are increasingly ones you've never heard of, because there's no international marketing department attached.
That gap is why we started this series.
Read next
Want the safe version first? The Korean beauty brands we'd tell a friend about first. Shopping this week? What we'd actually buy at Olive Young. Curious where the whole industry is going? The new generation of Korean beauty brands we're watching.
FAQ
What are the up-and-coming Korean skincare brands?
The ones worth watching are usually brands with strong domestic evidence and no international marketing — Zeroid from the clinic channel, goodal's vitamin C line, and 107's fermented vinegar range are three current examples. Around 75% of Olive Young's 2025 category winners were small or mid-size companies, so the pipeline is deep.
Is Zeroid available outside Korea?
Distribution is limited compared with the export-focused K-beauty brands. Its footprint has been built through Korean dermatology and pediatric clinics — roughly 70% and 80% of them respectively — rather than through international retail.
What is 107 skincare?
A Korean brand built on traditional fermented vinegar, originating from a vinegar brewery lineage and named for 107 family remedies. Unusually, it launched in the United States in 2020 and entered the Korean market afterward, in January 2021.
Are indie Korean beauty brands better than the big ones?
Not inherently, but the market has shifted toward them — roughly three-quarters of Olive Young's 2025 category winners were SMEs. The practical advantage is that indie brands here compete on formulation and repeat purchase rather than distribution muscle.
How do you decide what goes on this list?
Domestic evidence first — category performance, clinic adoption, repeat purchase — and international profile second. If a brand is already everywhere on your feed, it isn't on our radar. It's on yours.
